These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2724048)

  • 1. [The oral liquid form of vinburnine: biopharmaceutics].
    Sado PA; Gibassier D; Leverge R
    J Pharm Belg; 1989; 44(1):50-9. PubMed ID: 2724048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of modification of excipients for the bioavailability of vinburnine].
    Sado PA; Gibassier D; Leverge R
    J Pharm Belg; 1989; 44(3):221-9. PubMed ID: 2795425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biopharmaceutics of vincamine salts after oral administration in humans].
    Aiache JM; Turlier M; Sibaud Y
    Farmaco Prat; 1985 Mar; 40(3):87-100. PubMed ID: 3996561
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetic study of oral vincamine].
    Ventouras K; Schulz P; Doelker E; Boucherat J; Bari P
    Pharm Acta Helv; 1976; 51(11):334-42. PubMed ID: 1019177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relative bioavailability of vinburnine in man (microgranules/gels)].
    Sado PA; Gibassier D; Le Verge R; Acerbi D; Schiantarelli P
    J Pharm Belg; 1985; 40(5):308-22. PubMed ID: 4087124
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of sudden deafness. Apropos of the parenteral and peroral administration of Cerebroxine].
    Vincent Y; Ermens F
    Acta Otorhinolaryngol Belg; 1983; 37(1):88-94. PubMed ID: 6613569
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic study of vincamine teprosilate.
    Cadórniga R; Saiz Vadillo MC; Molina IT; Cadórniga L
    Int J Clin Pharmacol Res; 1984; 4(4):281-90. PubMed ID: 6500775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of two pharmaceutical preparations containing alkaloid vincamine administered orally to human subjects.
    Millart H; Lamiable D; Houin G; Plat M; Choisy H; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):581-6. PubMed ID: 6654533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability of vinburnine in man: importance of combination with ascorbic acid].
    Sado PA; Gibassier D; Leverge R
    J Pharm Belg; 1986; 41(1):17-28. PubMed ID: 3701564
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of nifedipine from different oral dosage forms in healthy volunteers.
    Leucuţa SE; Vida-Simiti L; Căprioară MG; Făgărăşan E; Olinic N; Manasia M; Vlaicu R
    Pharmazie; 1989 May; 44(5):336-8. PubMed ID: 2772014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic aspects of the sublingual administration of vincamine.
    Aiache JM; Delatte MC; Leblanc PP; Kantelip JP; Gomeni R; Steimer JL
    Biopharm Drug Dispos; 1990; 11(4):279-309. PubMed ID: 2340347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-compartmental modeling and kinetic parameter identification of the systemic distribution of vincamine after oral administration in the rat and in the man.
    Rognoni F; Viganó V; Periti P; Pirola LC
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):373-80. PubMed ID: 892955
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioavailability of bromazepam in man after single administration of an oral solution.
    Ascalone V; Cisternino M; Sicolo N; De Palo E
    Arzneimittelforschung; 1984; 34(1):96-8. PubMed ID: 6142717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic action of a combination of vincamine and piracetam in peripheral labyrinthine syndromes with a vascular component].
    Jiménez-Cervantes Nicolás JA; Ferrán Bernal J; Anula Suárez P; Gil Melgarejo JA
    An Otorrinolaringol Ibero Am; 1981; 8(2):131-60. PubMed ID: 7270822
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of dosage form on drug effect].
    Zathurecký L
    Pharmazie; 1972 Nov; 27(11):686-93. PubMed ID: 4650983
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.